The title of my talk is ‘Targeting RNA modifications in cancer’
My bio is as follows:
Michaela Frye completed her PhD in Frankfurt/Main in Germany in 2000 studying the role of epithelial defensins in Cystic Fibrosis. In 2001, she joined Cancer Research UK (CR-UK) in London as a Postdoctoral Fellow, where studied how stem cells form and maintain adult tissues. In 2007, Michaela started her independent research group at the Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute. She received a CR-UK Career Development Fellowship in 2007 and a CR-UK Senior Fellowship and an ERC Consolidator Grant in 2013 to study how dysregulation of stem cell function contributes to human diseases and cancer. In 2019, she accepted a Professorship at the DKFZ in Heidelberg Germany where her group studies mechanisms regulating gene expression regulate stem cell fate in normal tissues and cancer.